Journal of Diabetes and Its Complications
Volume 17, Issue 1 , Pages 34-38 , January 2003

Identification and characterization of high glucose and glucosamine responsive element in the rat osteopontin promoter

  • Sunao Asaumi

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Minoru Takemoto

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Koutaro Yokote

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Amy L Ridall

      Affiliations

    • Department of Basic Science, Dental Branch, University of Texas Houston-Health Science Center, Houston, TX 77030, USA
    • Department of Prosthodontics, Dental Branch, University of Texas Houston-Health Science Center, Houston, TX 77030, USA
    • ,
  • William T Butler

      Affiliations

    • Department of Basic Science, Dental Branch, University of Texas Houston-Health Science Center, Houston, TX 77030, USA
    • ,
  • Masaki Fujimoto

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Kazuki Kobayashi

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Harukiyo Kawamura

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Ayako Take

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Yasushi Saito

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • ,
  • Seijiro Mori

      Affiliations

    • Department of Clinical Cell Biology, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chiba 260-8670, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-43-226-2091; fax: +81-43-226-2095

Received 3 April 2002 ,Revised 7 May 2002 ,Accepted 15 May 2002.

References 

  1. Cantor H. The role of Eta-1/osteopontin in the pathogenesis of immunological disorders. Annals of the New York Academy of Sciences. 1995;760:143–150
  2. Chen Y-Q, Su M, Walia RR, Hao Q, Convington JW, Vaughan DE. Sp1 sites mediate activation of the plasminogen activator inhibitor-1 promoter by glucose in vascular smooth muscle cells. Journal of Biological Chemistry. 1998;273:8225–8231
  3. Comer FI, Hart GW. O-GlcNAc and the control of gene expression. Biochimica et Biophysica Acta. 1999;1473:161–171
  4. Craig AM, Bowden GT, Chambers AF, Spearman MA, Greenberg AH, Wright JA, et al. Secreted phosphoprotein mRNA is induced during multi-stage carcinogenesis in mouse skin and correlates with the metastatic potential of murine fibroblasts. International Journal of Cancer. 1990;46:133–137
  5. Goldberg HJ, Scholey J, Fantus IG. Glucosamine activates the plasminogen activator inhibitor 1 gene promoter through Sp1 DNA binding sites in glomerular mesangial cells. Diabetes. 2000;49:863–871
  6. Hoffman BB, Sharma K, Zhu Y, Ziyadeh FN. Transcriptional activation of transforming growth factor beta-1 in mesangial cell culture by high glucose concentration. Kidney International. 1998;54:1107–1116
  7. Kohri K, Nomura S, Kitamura Y, Nagata T, Yoshioka K, Iguchi M, et al. Structure and expression of the mRNA encoding urinary stone protein (osteopontin). Journal of Biological Chemistry. 1993;268:15180–15184
  8. Koo SH, Towle HC. Glucose regulation of mouse S(14) gene expression in hepatocytes: involvement of a novel transcription factor complex. Journal of Biological Chemistry. 2000;275:5200–5207
  9. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). Journal of Clinical Investigation. 1998;101:1468–1478
  10. Liaw L, Lombardi DM, Almeida MM, Schwartz SM, deBlois D, Giachelli CM. Neutralizing antibodies directed against osteopontin inhibit rat carotid neointimal thickening after endothelial denudation. Arteriosclerosis, Thrombosis, and Vascular Biology. 1997;17:188–193
  11. Malyankar UM, Hanson R, Schwartz SM, Ridall AL, Giachelli CM. Upstream stimulatory factor 1 regulates osteopontin expression in smooth muscle cells. Experimental Cell Research. 1999;250:535–547
  12. Molkentin JD, Olson EN. Combinatorial control of muscle development by basic helix-loop-helix and MADS-box transcription factors. Proceedings of the National Academy of Sciences of the United States of America. 1996;93:9366–9373
  13. Morisaki N, Takahashi K, Shiina R, Zenibayashi M, Otabe M, Yoshida S, et al. Platelet-derived growth factor is a potent stimulator of expression of intercellular adhesion molecule-1 in human arterial smooth muscle cells. Biochemical and Biophysical Research Communications. 1994;200:612–618
  14. Ridall AL, Daane EL, Dickinson DP, Butle WT. Characterization of the rat osteopontin gene: evidence for two vitamin D response elements. Annals of the New York Academy of Sciences. 1995;760:59–66
  15. Sawada Y, Noda M. An adipogenic basic helix-loop-helix-leucine zipper type transcription factor (ADD1) mRNA is expressed and regulated by retinoic acid in osteoblastic cells. Molecular Endocrinology. 1996;10:1238–1248
  16. Sawadogo M, Roeder RG. Interaction of a gene-specific transcription factor with the adenovirus major late promoter upstream of the TATA box region. Cell. 1985;43:165–175
  17. Senger DR, Perruzzi CA, Papadopoulos A. Elevated expression of secreted phosphoprotein I (osteopontin, 2ar) as a consequence of neoplastic transformation. Anticancer Research. 1989;9:1291–1300
  18. Shanahan CM, Cary NR, Metcalfe JC, Weissberg PL. High expression of genes for calcification-regulating proteins in human atherosclerotic plaques. Journal of Clinical Investigation. 1994;93:2393–2402
  19. Sodek J, Ganss B, McKee MD. Osteopontin. Critical Reviews in Oral Biology and Medicine. 2000;11:279–303
  20. Takemoto M, Yokote K, Nishimura M, Shigematsu T, Hasegawa T, Kon S, et al. Enhanced expression of osteopontin in human diabetic artery and analysis of its functional role in accelerated atherogenesis. Arteriosclerosis, Thrombosis, and Vascular Biology. 2000;20:624–628
  21. Takemoto M, Yokote K, Yamazaki M, Ridall AL, Butler WT, Matsumoto T, et al. Enhanced expression of osteopontin by high glucose in cultured rat aortic smooth muscle cells. Biochemical and Biophysical Research Communications. 1999;258:722–726
  22. Xie Y, Sakatsume M, Nishi S, Narita I, Arakawa M, Gejyo F. Expression, roles, receptors, and regulation of osteopontin in the kidney. Kidney International. 2001;60:1645–1657

PII: S1056-8727(02)00189-7

Journal of Diabetes and Its Complications
Volume 17, Issue 1 , Pages 34-38 , January 2003

Article Tools

* Image Usage & Resolution